Reply: Hyaluronic acid: A unique topical vehicle for the localized delivery of drugs to the skin [14]

Journal of the European Academy of Dermatology and Venereology

Volumn 20, Issue 10, 2006, Pages 1348-1349

  Chandrashekar, Laxmishac ^a  

^a JAWAHARLAL INSTITUTE OF POSTGRADUATE MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AMOROLFINE; CALCIPOTRIOL; CICLOPIROX; DICLOFENAC; HYALURONIC ACID; STEROID; TAZAROTENE;

DRUG ABSORPTION; DRUG DELIVERY SYSTEM; DRUG PENETRATION; DRUG RETENTION; DRUG USE; FALSE NEGATIVE RESULT; HUMAN; LETTER; ONYCHOMYCOSIS; PATCH TEST; PRIORITY JOURNAL; PSORIASIS; SKIN ABSORPTION; SKIN PENETRATION; STRATUM CORNEUM;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, TOPICAL; DERMATOLOGIC AGENTS; HUMANS; HYALURONIC ACID; SKIN; VEHICLES;

EID: 33750313982     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2006.01708.x     Document Type: Letter

References (3)

1. Brown M, Jones S. Hyaluronic acid: A unique topical vehicle for the localized delivery of drugs to the skin. J Eur Acad Dermatol Venereol 2005; 19: 308-318.
2. Lammintausta K, Kortekangas-Savolainen O. The usefulness of skin tests to prove drug hypersensitivity. Br J Dermatol 2005; 152: 968-974.
3. Brown MB, Ingham S, Moore A et al. A preliminary study of the effect of hyaluronan in drug delivery. In: Willoughby DA, ed. Hyaluronan in Drug Delivery. Royal Society of Medicine Press, London, 1995: 48-52.